Cooperation Market

A German university has developed a new biomarker and medical approach for the treatment of dementia and other memory impairment conditions. The development includes the discovery of a new microNRA biomarker associated with learning and memory as well as its therapeutic manipulation, in particular rescue learning impairment in dementia. The university is searching for licensees.

read on

A German university has developed an efficient medical approach for antibody- mediated therapies. The approach includes a new treatment regime of a combined drug administration, improving the efficacy of the antibody response. The combined treatment is based on the discovery of exosome-mediated protection of targeted tumor cells and the identification of a key target in exosome biogenesis. The university is searching for licensees.

read on

A German SME with established contacts to the academic community is active as one of the foremost providers of expression cloning, protein purification technologies and delivery technologies for proteins and nucleic acids. The proprietary protein products and services cover the entire drug discovery process. The SME is searching for partners for joint further development and commercial cooperations with technical assistance in drug and pharmceutical development.

read on

Scientists at a German university developed a test to track cellular ageing as required in quality control of cell preparations. It makes use of the epigenetic signature as a biomarker for various cell types. It is simple to implement and cell culture experiments are reproducible. Pharmaceutical and medical companies interested in commercial use are sought for licensing.

read on

Scientists from two German universities have developed a novel approach for the synthesis of glycosylated peptides. Applications are in biotechnology, e.g. in cell-cell communication, cellular differentiation, protein folding and others. The new production process is faster and easier than conventional methods and comprises only a few steps. Industrial partners are sought for commercial use under license agreement.

read on

At a German research institute a process and a facility for chilling and freezing food has been developed. The foodstuffs are placed in a special chamber. The pressure in this facility is lowered to an extent that the product chills and freezes due to evaporation of moisture. Stickiness of the product is prevented by vibration during the chilling and freezing process. The potential partner should join further development of a complete prototype and market launch.

read on

A German university developed a new advanced blood test based on gene signatures to detect acute myeloid leukemia at an early stage. The analysis of peripheral blood only is sufficient for the test. Pharmaceutical and medical technology companies are offered the rights for commercial exploitation.

read on

A small German company has developed an efficient technology for the quick defrosting of blood plasma to be applied in medical fields like anaesthetics, transfusion medicine and blood banks. The SME-sized company is looking for commercial partners dealing with medtech products and services in the mentioned medical sectors. Technical cooperation and/or commercial agreement sought.

read on

Scientists from a German university developed a new therapeutic and prophylactic approach for pancreatitis. The technology refers to the use of an oral elastaste inhibitor for the prophylaxis and therapy of pancreatitis. The scientists are interested in furter development and adaption to specific needs and / or licensing.

read on

Scientists of a university in the Northeast of Germany developed a new method for decontaminating and coating surfaces of medical and pharmaceutical products for an effective protection from colonisation of bacteria. They are offering the granted patent for sale or licensing. The scientists are also interested in a R&D cooperation.

read on